Inirerekomenda ng HTAC na maaring gamitin sa pagbabakuna ng mga kabataang 12-17 taong gulang ang mga COVID-19 vaccine na Pfizer-BioNTech at Moderna sa 2022. Link sa HTAC Recommendation: Pediatric Vaccination for the prevention of COVID-19 Link sa English Version: HTAC Guidance: COVID-19 Vaccination among the Adolescent Population Mga Bakuna para sa COVID-19 na sakop ng Emergency Use Authorization o EUA Ang Food and Drug Administration Philippines (FDA Philippines) ay continue reading : Gabay ng HTAC para sa Pagbabakuna ng Kabataang Pilipino
Pediatric Vaccination for the prevention of COVID-19 (12 to 17 years)
Date of publication: October 28, 2021 Decision of the Secretary of Health: Approved Pursuant to the role of the Health Technology Assessment Council (HTAC) to develop coverage recommendations particularly in the selection and financing of COVID-19 vaccines using the Evaluation Framework set by the HTAC, this report presents all currently available evidence considered in the assessment of continue reading : Pediatric Vaccination for the prevention of COVID-19 (12 to 17 years)
Booster and Additional Dose for the Prevention of COVID-19
Date of publication: November 03, 2021 Decision of the Secretary of Health: Approved Pursuant to the role of the Health Technology Assessment Council (HTAC) to develop coverage recommendations particularly in the selection and financing of COVID-19 vaccines using the Evaluation Framework set by the HTAC, this report presents all currently available evidence considered in the assessment of continue reading : Booster and Additional Dose for the Prevention of COVID-19